Skip Navigation



Carcinogenesis Advance Access published online on January 3, 2008

Carcinogenesis, doi:10.1093/carcin/bgm243
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
29/2/427    most recent
bgm243v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Muller, J.
Right arrow Articles by Kirsch-Volders, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, J.
Right arrow Articles by Kirsch-Volders, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells

Julie Muller1,{dagger}, Ilse Decordier2, Peter Hoet3, Noömi Lombaert2, Leen Thomassen4, François Huaux1, Dominique Lison1 and Micheline Kirsch-Volders2

1 Université catholique de Louvain, Unité de toxicologie industrielle et médecine du travail, Avenue Mounier, 53.02; 1200 Bruxelles, Belgium
2 Vrije Universiteit Brussel, Laboratorium voor Cellulaire Genetica, Pleinlaan 2, 1050 Brussel, Belgium
3 Katholieke Universiteit Leuven, Laboratorium voor Pneumologie, Eenheid Longtoxicologie, Herestraat 49, 3000 Leuven, Belgium
4 Katholieke Universiteit Leuven, Centrum voor Oppervlaktechemie en Katalyse, Kasteelpark Arenberg 23, 3001 Heverlee, Belgium

{dagger} Corresponding author : Julie Muller, Université catholique de Louvain, Unité de Toxicologie Industrielle et de Médecine du Travail, Avenue Mounier 53.02, B-1200 Bruxelles, Belgium, Tel : +32 2 764 53 36, Fax : +32 2 764 53 38, E-mail : julie.muller{at}uclouvain.be

Information on the toxicity of carbon nanotubes (CNT) is still fragmentary but indicates that these particles can induce adverse effects. We previously demonstrated in rats that, when purified multi-wall carbon nanotubes (MWCNT) reach the lung, they are biopersistent and induce lung inflammation as well as fibrosis. The present study was designed to address the genotoxic potential of this material in the same species.

In vivo, micronuclei (MN) were assessed in type II pneumocytes 3 days after a single intra-tracheal administration of MWCNT (0.5 or 2 mg). We also used the cytokinesis-block micronucleus assay in rat lung epithelial cells (RLE) exposed in vitro to MWCNT (10, 25, 50 µg/ml). Finally, we applied a human pancentromeric fluorescent probe (Fluorescent In Situ Hybridisation, FISH assay) to differentiate clastogenic and/or aneugenic mechanisms in a human epithelial cell line (MCF-7).

In vivo, we found a significant and dose-dependent increase in micronucleated pneumocytes after a single administration of MWCNT (about a 2-fold increase at the highest dose). In vitro, we observed a significant increase of micronuclei in epithelial cells after exposure to MWCNT (up to a 2-fold increase at the cytotoxic dose of 50 µg/ml). Finally, we found that MWCNT induced both centromere-positive and negative micronuclei in MCF-7 cells. Overall, this study provides the first evidence of the potential of MWCNT to induce clastogenic as well as aneugenic events.

Received May 23, 2007; revised October 25, 2007; accepted October 26, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.